Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Hand Surg Eur Vol ; 44(5): 532-536, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30764703

ABSTRACT

Hospital Episode Statistics (HES) include freely accessible records of all hospital episodes in England. We analysed HES from 1998-1999 to 2014-2015 for diagnoses of hand fractures, tendon injuries, nerve injuries, blood vessel injuries, traumatic amputations and nail bed injuries. Population data were used to calculate the incidence. The overall incidence of the injuries increased from 70 to 110 per 100,000. There were especially large increases in the incidence of fractures in the over 75 years age group and nail bed injuries in the 0-14 years age group. The incidence of nerve injuries also increased. We conclude from this study that HES is a useful tool. The information from HES may help plan service provision and also highlight important clinical problems that may benefit from further research.


Subject(s)
Hand Injuries/epidemiology , Adolescent , Adult , Age Distribution , Aged , Amputation, Traumatic/epidemiology , Child , Child, Preschool , England/epidemiology , Female , Fractures, Bone/epidemiology , Humans , Infant , Infant, Newborn , Male , Middle Aged , Peripheral Nerve Injuries/epidemiology , Population Dynamics/statistics & numerical data , Sex Distribution , Tendon Injuries/epidemiology , Vascular System Injuries/epidemiology , Wrist Injuries/epidemiology , Young Adult
2.
Plast Reconstr Surg ; 143(2): 512-518, 2019 02.
Article in English | MEDLINE | ID: mdl-30688894

ABSTRACT

BACKGROUND: Dupuytren's disease is a very common, highly heritable palmar fibromatosis. In a recent genome-wide association study, 26 single-nucleotide polymorphisms were found to be associated with development of Dupuytren's disease. The authors generated a weighted genetic risk score based on the genotype at these single-nucleotide polymorphisms. In two independent cohorts, they tested the association among high weighted genetic risk score, clinical features that predict a high risk of recurrence, and recurrence after surgery. METHODS: Clinical data were obtained from patient questionnaires and clinical records, with missing data accounted for by imputation. Genotyping was performed as part of the recent genome-wide association study. Logistic regression was performed to study the association among weighted genetic risk score, high-risk clinical features, and recurrence, with a weighted genetic risk score analyzed as a continuous variable, and also grouped into four categories. RESULTS: Using univariable logistic regression, a high weighted genetic risk score was associated with the presence of all high-risk clinical features: early age of onset, bilateral disease, ectopic disease, and a positive family history (p ≤ 0.004). After multivariable logistic regression accounting for these factors, an increased weighted genetic risk score was still associated with the need for repeated Dupuytren's disease surgery (p = 0.004). CONCLUSIONS: The authors' results suggest that a weighted genetic risk score is useful in predicting the risk of disease recurrence, and may be used by surgeons to personalize prognostication. In the future, a weighted genetic risk score may be useful for determining the most appropriate initial surgical procedure in patients with Dupuytren's disease. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.


Subject(s)
Dupuytren Contracture/surgery , Neoplasm Recurrence, Local/genetics , Age of Onset , Aged , Cohort Studies , Dupuytren Contracture/genetics , Female , Genome-Wide Association Study , Genotype , Humans , Male , Neoplasm Recurrence, Local/diagnosis , Netherlands , Pilot Projects , Polymorphism, Single Nucleotide , Prognosis , Risk Factors , Surveys and Questionnaires/statistics & numerical data , United Kingdom
3.
Injury ; 49(10): 1922-1926, 2018 Oct.
Article in English | MEDLINE | ID: mdl-30082111

ABSTRACT

BACKGROUND: Recent national (NICE) guidelines in England recommend that initial debridement and wound excision of open tibial fractures take place within 12 h of the time of injury, a change from the previous target of 24 h. This study aims to assess the effect of timing of the initial debridement and wound excision on major infective complications, the impact of the new guidance, and the feasibility of adhering to the 12 h target within the infrastructure currently existing in four major trauma centres in England. METHODS: A retrospective review was performed of Gustilo-Anderson grade 3B open tibial fractures presenting acutely to four Major Trauma Centres (MTCs) in England with co-located plastic surgery services over a ten-month period. The incidence of deep infective complications was compared between patients who underwent initial surgery according to the new NICE guidance and those who did not. Patients warranting emergency surgery for severely contaminated injury, concomitant life-threatening injury and neurovascular compromise were excluded. Multi-variable logistic regression analysis was performed to assess the effect of timing of surgical debridement on development of deep infective complications. RESULTS: 112 patients with 116 fractures were included. Six fractures (5.2%) developed deep infective complications. 38% (n = 44) underwent primary debridement within 12 h and 90% within 24 h. There was no significant difference in the incidence of major infective complications if debrided in less than or greater than 12 h (4.5% vs 5.6%, p = 1.00). Logistic regression found no significant relationship between timing of wound excision and development of deep infection. There was no significant decrease in mean time to debridement following introduction of new national guidance (13.6 vs 16.1 h) in these four MTCs. CONCLUSION: Overall, the rate of deep infection in high energy open tibial fractures managed within the four major trauma centes is low. Achieving surgical debridement within 12 h is challenging within the current infrastructure, and it is unclear whether adhering to this target will significantly affect the incidence of severe infective complications. Debridement within 24 h appears achievable. If a 12-h target is to be met, it is vital to ensure dedicated orthoplastic capacity is adequately resourced.


Subject(s)
Debridement , Fractures, Open/surgery , Surgical Wound Infection/prevention & control , Tibial Fractures/surgery , Trauma Centers , Adolescent , Adult , Aged , Aged, 80 and over , Debridement/methods , England , Fracture Fixation, Internal , Humans , Male , Middle Aged , Retrospective Studies , Treatment Outcome , Wound Closure Techniques , Young Adult
4.
Sci Rep ; 5: 9278, 2015 Mar 23.
Article in English | MEDLINE | ID: mdl-25797118

ABSTRACT

In vitro models of fibrotic phenomena are often based on the fibroblast-myofibroblast transition as the contraction-triggering cellular event. There are, however, multiple sources of concern regarding the appropriateness of such models; a first and widely investigated issue is the often inappropriate nature of the interactions between mesenchymal cells and surrounding/underlying matrix/substrate. A second set of problems concerns the composition of the fluid phase, which includes both dispersed/dissolved paracrine messengers and matrix elements. In this study, we have focused on the effects that serum may generate. We have observed that A) serum causes high variability in the expression of typical markers of myofibroblast differentiation (ED-A fibronectin and α-Smooth Muscle Actin) upon treatment with TGF-ß1; this is probably due to intrinsic variability of cytokine concentrations in different batches of serum. B) the fibrillization of endogenous fibronectin is partially hampered and its localization changed from ventral (on the substrate) to dorsal (upper surface); the latter morphology appears to be largely overlooked in literature, even though it may have a significant role in terms of mechanotransductive signaling. This quite dramatic change possibly occurs as a result of competition with serum proteins, although our data seem to rule out a direct role of serum fibronectin.


Subject(s)
Culture Media/chemistry , Fibroblasts/metabolism , Fibronectins/chemistry , Myofibroblasts/metabolism , Serum/chemistry , Actins/genetics , Actins/metabolism , Cell Differentiation , Culture Media/pharmacology , Dermis/drug effects , Dermis/metabolism , Dermis/ultrastructure , Fibroblasts/drug effects , Fibroblasts/ultrastructure , Fibronectins/genetics , Fibronectins/metabolism , Fibronectins/pharmacology , Gene Expression , Humans , Myofibroblasts/drug effects , Myofibroblasts/ultrastructure , Primary Cell Culture , Signal Transduction , Transforming Growth Factor beta1/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL